Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lemborexant driving performance study
NCT02583451Phase 1Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Nov 2015
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of lemborexant in Insomnia (5 arms), sponsored by Eisai Co., Ltd. Primary endpoint: Standard Deviation of Lateral Position at Day 72. Started Nov 2015; status: completed.
02
Drugs
lemborexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT02583451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02583451.